Stockreport

Ascendis Pharma A/S Touts €683M Product Revenue, Feb PDUFA Catalyst at JPM Healthcare Conference [Yahoo! Finance]

TEIJIN LTD ADR  (TINLY) 
NASDAQ:AMEX Investor Relations: teijin.com/ir
PDF growth, expanding international commercialization, and multiple 2026 clinical and regulatory milestones during a presentation and Q&A at the 44th Annual J.P. Morgan Heal [Read more]